Delhi HC Confirms ESOP Discount Deductible Under Section 37(1) — PVR Ltd Case Explained

The Story

No cash left the company’s account. No invoice was raised. And yet, the Delhi High Court has confirmed, a company can still claim a tax deduction for the cost of an Employee Stock Option Plan, because a discount given up is, in the eyes of Section 37(1), every bit as much an expense as money actually spent.

The dispute traces back to an appeal admitted by the Delhi High Court on 30 April 2013, asking a single question: was the difference between the price at which PVR Ltd. offered stock options to employees under its ESOP and Employee Stock Purchase Scheme (ESPS), and the prevailing market price of those shares on the date of grant, allowable as revenue expenditure under Section 37(1) of the Income-tax Act, 1961? The Assessing Officer had denied the claim, treating the ESOP discount as a contingent liability rather than a real, deductible expense.

Sidebar: the case that ultimately settled this was not even PVR’s own. While the appeal sat pending, the Karnataka High Court decided CIT v. Biocon Ltd. in 2020, and its reasoning did the heavy lifting the Delhi High Court would later adopt wholesale: an ESOP works like a deferred, vesting-linked wage. Employees earn the right to buy shares cheap only by staying and working through the vesting period, so the discount the company absorbs is not a gift or a capital loss, it is the price of retaining talent, paid in the currency of foregone share value instead of cash.

The Delhi High Court reproduced the Karnataka High Court’s reasoning in full: Section 37(1) permits deduction for expenditure laid out or expended and does not require an actual cash pay-out; the word expenditure in the section includes a loss; and where an ESOP vests over several years, the company’s liability to honour that vesting crystallises progressively, the eventual exercise of the option merely quantifies an already-existing liability, rather than creating a fresh contingent one.

The Delhi High Court noted it had already been here before: it had followed the same Biocon reasoning in PCIT v. New Delhi Television Ltd. (2018) 99 taxmann.com 401 (Delhi), and had dismissed two subsequent Revenue appeals on identical issues, ITA 107/2015 and ITA 214/2019. Following that settled line, the Court decided the question in PVR Ltd.’s favour, set aside the Tribunal’s contrary finding, and disposed of the appeal.

Why It Matters

ESOPs and ESPSs are now a standard retention tool well beyond the technology sector. This ruling reconfirms, for any company or advisor still uncertain, that the accounting discount recognised on ESOP grants translates into a genuine, allowable Section 37(1) tax deduction, not a permanently disallowed capital item, provided the vesting-based liability is properly computed and documented year on year.

Key Takeaways

• The Delhi High Court, in PVR Ltd. v. CIT, held that the discount between the grant price and market price of shares issued under an ESOP or ESPS is allowable as revenue expenditure under Section 37(1), and set aside a contrary Tribunal finding.
• The ruling follows the Karnataka High Court’s decision in CIT v. Biocon Ltd. (2020) 121 taxmann.com 351, which held that ESOP discount is an ascertained, not contingent, liability that crystallises progressively as options vest.
• Section 37(1)’s reference to expenditure includes a loss; a company issuing shares at a discount and absorbing the difference has incurred expenditure for the purposes of that section, even without any cash outflow.
• This is not a novel position for the Delhi High Court specifically, it has already followed the same reasoning in PCIT v. New Delhi Television Ltd. and dismissed two subsequent Revenue appeals on identical facts.
• The primary object of an ESOP scheme is treated as securing consistent employee services rather than wasting capital.

Practical Implications

Companies with existing or planned ESOP/ESPS schemes should ensure their tax computation properly recognises the vesting-period discount as a Section 37(1) deduction each year the relevant tranche vests. Firms preparing tax positions or responding to scrutiny assessments on this point now have a well-settled Delhi High Court line to rely on. Firms should nonetheless ensure proper documentation of the vesting schedule and the discount computation each year.

Action Checklist

• Review any client company’s ESOP/ESPS tax computations to confirm the vesting-period discount has been claimed as a Section 37(1) deduction in the relevant years.
• Maintain a clear, year-by-year record of vesting schedules and the market-price-to-grant-price discount computation.
• Where an Assessing Officer disallows an ESOP discount deduction as a contingent liability, cite this ruling alongside Biocon and the Delhi High Court’s prior NDTV line.
• For companies outside the Delhi High Court’s jurisdiction, confirm whether the relevant jurisdictional High Court has an equivalent ruling.
• Flag to finance teams that this deduction requires no cash outflow tracking, only accurate vesting and discount computation records.

Relevant Sections, Rules and Notifications

• Section 37(1), Income-tax Act, 1961 (general deduction for business expenditure)
• CIT v. Biocon Ltd. (2020) 121 taxmann.com 351 (Karnataka), followed
• PCIT v. New Delhi Television Ltd. (2018) 99 taxmann.com 401 (Delhi), followed
• Bharat Movers and Rotork Controls India (P) Ltd. (Supreme Court authorities on deductibility of liabilities requiring future quantification)

FAQs

Q: Can a company claim a tax deduction for ESOP costs even though it never actually pays cash for the discount given to employees?
A: Yes, per this ruling and the Karnataka High Court’s Biocon decision it follows, Section 37(1) does not require an actual cash pay-out.

Q: Is the ESOP discount deductible all at once, or does it need to be spread over the vesting period?
A: The reasoning adopted treats the liability as crystallising progressively as each tranche vests, so the deduction should track the vesting schedule.

Q: Does this ruling apply outside Delhi?
A: This specific judgment is a Delhi High Court ruling and is directly binding within that jurisdiction, but follows the influential Karnataka High Court Biocon ruling.

Prepared by Finoscape Editorial Team — hello@finoscape.com. This article is for general informational purposes and does not constitute legal or professional advice, and is based on a full reproduction of the High Court’s judgment as published by professional tax media (TaxGuru) rather than a certified copy obtained directly from the Court’s own record. The exact date of this order was not independently verifiable this cycle (available only to TaxGuru’s paid subscribers). Practitioners should independently verify the judgment and its date before citing it in client advice or submissions. Reading time: 5 minutes.